91 research outputs found
Bone development in transgender adolescents treated with gnrh analogues and subsequent gender-affirming hormones
Context: Hormonal interventions in adolescents with gender dysphoria may have adverse effects, such
as reduced bone mineral accrual.
Objective: To describe bone mass development in adolescents with gender dysphoria treated with
gonadotropin-releasing hormone analogues (GnRHa), subsequently combined with gender-affirming
hormones.
Design: Observational prospective study.
Subjects: 51 transgirls and 70 transboys receiving GnRHa and 36 transgirls and 42 transboys receiving
GnRHa and gender-affirming hormones, subdivided into early- and late-pubertal groups.
Main Outcome Measures: Bone mineral apparent density (BMAD), age- and sex-specific BMAD z-scores,
and serum bone markers.
Results: At the start of GnRHa treatment, mean areal bone mineral density (aBMD) and BMAD values were
within the normal range in all groups. In transgirls, the mean z-scores were well below the population mean.
During 2 years of GnRHa treatment, BMAD stabilized or showed a small decrease, whereas z-scores decreased
in all groups. During 3 years of combined administration of GnRH
Male-to-female transsexual subtypes: Sexual arousal with cross-dressing and physical measurements
- …